ATE455536T1 - Topische zusammensetzung zur behandlung von schuppenflechte - Google Patents

Topische zusammensetzung zur behandlung von schuppenflechte

Info

Publication number: ATE455536T1
Authority: AT; Austria
Prior art keywords: treatment; psoriasis; psu; topical composition; moisturising
Prior art date: 2006-06-12

Application number

AT07380166T

Other languages

English (en)

Inventor

Rodriguez Cristina M Fernandez

Galvan Emilio Barja

Original Assignee

Rodriguez Cristina M Fernandez

Galvan Emilio Barja

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-12

Filing date

2007-06-11

Publication date

2010-02-15

2007-06-11 Application filed by Rodriguez Cristina M Fernandez, Galvan Emilio Barja filed Critical Rodriguez Cristina M Fernandez

2010-02-15 Application granted granted Critical

2010-02-15 Publication of ATE455536T1 publication Critical patent/ATE455536T1/de

Links

230000000699 topical effect Effects 0.000 title abstract 2
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
201000004681 Psoriasis Diseases 0.000 abstract 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 abstract 1
229940124091 Keratolytic Drugs 0.000 abstract 1
244000050054 Rosa moschata Species 0.000 abstract 1
235000000657 Rosa moschata Nutrition 0.000 abstract 1
NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 abstract 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000002421 anti-septic effect Effects 0.000 abstract 1
230000009286 beneficial effect Effects 0.000 abstract 1
229960001102 betamethasone dipropionate Drugs 0.000 abstract 1
CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 abstract 1
239000004202 carbamide Substances 0.000 abstract 1
239000003974 emollient agent Substances 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
230000001530 keratinolytic effect Effects 0.000 abstract 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000001172 regenerating effect Effects 0.000 abstract 1
239000010666 rose oil Substances 0.000 abstract 1
229960004889 salicylic acid Drugs 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
239000003871 white petrolatum Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT07380166T 2006-06-12 2007-06-11 Topische zusammensetzung zur behandlung von schuppenflechte ATE455536T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES200601574A ES2288133B1 (es)	2006-06-12	2006-06-12	Composicion topica para el tratamiento de la psoriasis.

Publications (1)

Publication Number	Publication Date
ATE455536T1 true ATE455536T1 (de)	2010-02-15

Family

ID=38457686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07380166T ATE455536T1 (de)	2006-06-12	2007-06-11	Topische zusammensetzung zur behandlung von schuppenflechte

Country Status (6)

Country	Link
EP (1)	EP1867322B1 (de)
AT (1)	ATE455536T1 (de)
DE (1)	DE602007004381D1 (de)
ES (1)	ES2288133B1 (de)
PL (1)	PL1867322T3 (de)
PT (1)	PT1867322E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20110098267A1 (en) *	2008-02-07	2011-04-28	Synta Pharmaceuticals Corporation	Topical formulations for the treatment of psoriasis
US20090258098A1 (en) *	2008-04-15	2009-10-15	Lane Rolling	Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
ES2362066B1 (es) *	2009-11-23	2012-05-25	Juan Barroso Abril	Preparación combinada para el tratamiento de la psoriasis.
RU2489144C2 (ru) *	2011-06-07	2013-08-10	Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО АКРИХИН")	Фармацевтическая композиция для лечения заболеваний кожи и способ ее получения
CN102652772B (zh) *	2012-05-15	2013-09-11	牛丽丽	一种治疗银屑病及神经性皮炎的中草药丸
ES2562085B1 (es) *	2014-09-02	2016-07-07	Amedyn Healthcare, S.L.	Crema para el tratamiento de pieles con estados descamativos y procedimiento de fabricación de dicha crema
CN113318069A (zh) *	2021-05-18	2021-08-31	南方医科大学皮肤病医院	一种用于治疗银屑病的抗炎外用乳膏及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4740372A (en) *	1986-09-17	1988-04-26	Ljubomir Boncic	Composition for treating psoriasis vulgaris and a method for its preparation
EP0717994A1 (de) *	1994-07-07	1996-06-26	Ignacio Anton Lujambio Galdeano	Neue zusammensetzung zur topischen behandlung der psoriasis
ES2083333B1 (es) *	1994-09-22	1997-01-16	Corral Begona Gozalo	Crema para el tratamiento de la psoriasis.
IT1320192B1 (it) *	2000-05-12	2003-11-26	Giovanni Summo	Composizione terapeutica per la cura della psoriasi.
ES2188426B1 (es)	2001-12-12	2004-11-16	Rosalia Pidal Fernandez	Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
RO120529B1 (ro)	2002-05-13	2006-03-30	Institutul De Tehnologie Chimică - Itec S.A.	Compoziţie antioxidantă pe bază de extracte naturale, pentru tratarea psoriazisului
BG65352B1 (bg) *	2002-05-16	2008-03-31	"Софарма" Ад	Средство за лечение на псориазис
ES2231007B2 (es) *	2003-10-13	2006-09-16	Alfredo Garcia Beltran	Crema para el tratamiento de la psoriasis.
SE0402029D0 (sv)	2004-08-17	2004-08-17	Synphora Ab	Prostaglandin a derivatieves for the treatment of psoriasis
US20060078580A1 (en) *	2004-10-08	2006-04-13	Mediquest Therapeutics, Inc.	Organo-gel formulations for therapeutic applications
WO2006102004A2 (en) *	2005-03-16	2006-09-28	Taro Pharmaceuticals U.S.A., Inc.	A stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same

2006
- 2006-06-12 ES ES200601574A patent/ES2288133B1/es not_active Expired - Lifetime
2007
- 2007-06-11 PT PT07380166T patent/PT1867322E/pt unknown
- 2007-06-11 DE DE602007004381T patent/DE602007004381D1/de active Active
- 2007-06-11 PL PL07380166T patent/PL1867322T3/pl unknown
- 2007-06-11 EP EP07380166A patent/EP1867322B1/de not_active Not-in-force
- 2007-06-11 AT AT07380166T patent/ATE455536T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2288133A1 (es)	2007-12-16
DE602007004381D1 (de)	2010-03-11
PL1867322T3 (pl)	2010-06-30
ES2288133B1 (es)	2008-09-16
PT1867322E (pt)	2010-04-07
EP1867322A1 (de)	2007-12-19
EP1867322B1 (de)	2010-01-20

Similar Documents

Publication	Publication Date	Title
DE602007004381D1 (de)	2010-03-11	Topische Zusammensetzung zur Behandlung von Schuppenflechte
ATE412417T1 (de)	2008-11-15	Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten
BR0207663A (pt)	2005-10-25	Uso de inibidores de egfr naturais para prevenir os efeitos colaterais devido à terapia com retinóides, sabões e outros estìmulos que ativam o receptor do fator de crescimento epidérmico
ATE339187T1 (de)	2006-10-15	Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
BRPI0414800A (pt)	2006-11-14	composições de higiene oral baseadas em morinda citrifolia e seus usos
BR0213612A (pt)	2004-08-24	Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
AR005234A1 (es)	1999-04-28	Un tratamiento para la piel estructuralmente deteriorada y composicion cosmetica utilizada en el mismo
ATE281143T1 (de)	2004-11-15	Verwendung einer biochinone enthaltenden wirkstoffkombination zur herstellung kosmetischer oder dermatologischer zubereitungen zur behandlung und prophylaxe von kopfschuppen
EP2114362A4 (de)	2013-12-18	Kosmetische zusammensetzung zur hautbleichung mit arctiin, arctigenin oder einer mischung daraus als wirkstoff
ATE461697T1 (de)	2010-04-15	Phospholipidderivate von valproinsäure und ihre kombinationen
WO2001028491A2 (en)	2001-04-26	Method and composition for the treatment of dermatologic diseases
DE69832710D1 (de)	2006-01-12	Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
BRPI0114344B8 (pt)	2021-05-25	composto retinóide, seu uso, sua composição farmacêutica e seu processo de preparação
ATE414526T1 (de)	2008-12-15	Zubereitungen zur behandlung von arthritischen erscheinungen
DK284386A (da)	1986-12-19	Farmaceutisk praeparat mod hudlidelser
GT199900081A (es)	2000-11-30	Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
CY1109507T1 (el)	2014-08-13	Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
BRPI0415136A (pt)	2006-11-28	método para a diminuição da produção de sebo
ES2573478T3 (es)	2016-06-08	Utilización de composiciones que comprenden por lo menos un lignano y/o neolignano para modular la tasa de testosterona
BRPI0409881A (pt)	2006-05-23	compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
DE60316724D1 (de)	2007-11-15	Pharmazeutische zusammensetzung enthaltend calcitriol und clobetasol propionate
BRPI0417116A (pt)	2007-03-06	usos de uma quantidade eficaz de ondansetron e composição para tratamento tópico de uma inflamação
EA200700044A1 (ru)	2007-08-31	Композиция для местного применения
DE69927260D1 (de)	2005-10-20	Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
KR910009995B1 (ko)	1991-12-10	펜테테인-s-술폰산을 함유하는 화장용 조성물

Legal Events

Date	Code	Title	Description
2010-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties